// App-Quantinova.ai

: Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection

Researchers

Presenter

  • Peter Kamstrup

Principal Investigators

  • Josefin Eklöf

  • Nils Hoyer

  • Charlotte Suppli Ulrik

  • Lars Pedersen

  • Therese S. Lapperre

  • Zitta Barrella Harboe

  • Uffe Bodtger

  • Rasmus Dahlin Bojesen

  • Kjell Erik Julius Håkansson

  • Casper Tidemandsen

  • Karin Armbruster

  • Andrea Browatzki

  • Howraman Meteran

  • Christian Niels Meyer

  • Kristoffer Grundtvig Skaarup

  • Mats Christian Højbjerg Lassen

  • Jens D. Lundgren

  • Tor Biering-Sørensen

  • Jens-Ulrik Stæhr Jensen

Medical Centers

  • Department of Pathology, Slagelse Hospital, Slagelse, Denmark

  • Department of Respiratory Medicine, Copenhagen University Hospital-Hvidovre, Hvidovre, Denmark

  • 10Department of Neurology, Zealand University Hospital Roskilde Denmark

  • Department of Reumatology/C, Copenhagen University Hospital Gentofte, Hellerup, Denmark

  • Section of Respiratory Medicine, Department of Medicine, Copenhagen University Hospital-Herlev and Gentofte, Hellerup, Denmark

  • Department of Respiratory Medicine, University Hospital Bispebjerg, Copenhagen, Denmark

  • Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital-North Zealand, Hilleroed, Denmark

  • Internal Medicine, Naestved Hospital, Naestved, Denmark

  • University Hospital-Rigshospitalet, Hellerup, Denmark

  • CHIP, Department of Infectious Diseases, Section 2100, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Locations

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved